Conspicuously, TOX expression is significantly correlated to survival in six cancer types including LUAD, brain glioma, brain astrocytoma, breast cancer, skin melanoma, and bladder transitional cell carcinoma (Table 1). Here, TOX is linked to breast carcinoma.